From 68990249a83945db5199d243aef88f15bd04e204 Mon Sep 17 00:00:00 2001 From: Borja Robert Date: Tue, 20 Feb 2024 12:44:07 +0100 Subject: [PATCH] Auto saved by Logseq --- pages/STOP2030___Web___Update 2024___02.md | 6 ++++-- 1 file changed, 4 insertions(+), 2 deletions(-) diff --git a/pages/STOP2030___Web___Update 2024___02.md b/pages/STOP2030___Web___Update 2024___02.md index b250973a..f51ccdca 100644 --- a/pages/STOP2030___Web___Update 2024___02.md +++ b/pages/STOP2030___Web___Update 2024___02.md @@ -94,7 +94,7 @@ - - ### Project - Trabajamos para hacer 2 ensayos clínicos - - Un safety and effectiveness study + - Proposed safety and effectiveness study - Primary objective: evaluate and compare safety of the [[FDC]] against [[albendazole]] alone via [[MDA]] in two study areas in [[Kenya]] and [[Ghana]] - Secondary objectives: - Evaluate the effectiveness of one round of [[MDA]] with [[FDC]] vs [[albendazole]] against [[STH]] by microscopy @@ -105,7 +105,9 @@ - Genomic resistance - Sample [[size]]: around 20k - Target population: School based - - Epidemiologic conditions on the sites: T + - Epidemiologic conditions on the sites: T. trichiura ongoing transmission areas + - Countries: [[Ghana]] and [[Kenya]] + - Proposed acceptability and feasiblity study - Nuestros objetivos: - Overall goal: Support the achievement of the [[WHO]] 2030 NTD Roadmap for [[STH]] and beyond - Project purpose: Advance and accelerate an innovative pharmacological tool to support the elimination goals against [[STH]] species, especially those poorly responsive to current treatment regimens \ No newline at end of file